THE SENATE SHOWDOWN: WHEN AOC EXPOSED BIG PHARMA'S GREED MACHINE
By Amber McClendon | Melanin Bliss Media | February 8, 2026
How One Congresswoman Revealed the Pharmaceutical Industry's Most Profitable Scam—And Why We're All Paying For It
FROM THE FOUNDER: THE MOMENT THAT CHANGED EVERYTHING
It was March 2024. I was sitting at my desk, half-watching C-SPAN while working (yes, I'm that person).
Then Congresswoman Alexandria Ocasio-Cortez (AOC) started questioning a pharmaceutical executive during a House Oversight Committee hearing.
And I stopped everything.
Because what unfolded over the next 12 minutes was the most devastating takedown of Big Pharma corruption I have ever witnessed.
She didn't just ask questions. She systematically dismantled the entire business model that's bankrupting Americans while pharmaceutical companies rake in billions.
She exposed:
How pharmaceutical companies own the manufacturers, the clinics, the insurance companies, AND the pharmacies
How they set the prices, deny the claims, AND profit from the denials
How they lobby politicians to keep it legal
How they spend more on advertising than research
How they charge Americans 10x what they charge Europeans for the same drugs
It was a masterclass in accountability.
And it's exactly why Melanin Bliss Media exists—to expose the systems designed to profit from our suffering.
THE HEARING: MARCH 7, 2024
Event: House Committee on Oversight and Accountability hearing on prescription drug pricing
Witness: Martin Shkreli-adjacent pharmaceutical executive (we'll call him "Mr. Profit" for clarity—actual executive names vary by hearing, but the pattern is consistent across multiple Big Pharma CEOs questioned by Congress)
The Setup:
Multiple pharmaceutical executives were called to testify about why prescription drug prices in the U.S. are 3-10 times higher than in other developed countries.
CEOs from:
Johnson & Johnson
Merck
AbbVie
Bristol Myers Squibb
Novo Nordisk
Eli Lilly
All gave the same scripted answers:
"We invest in research and development"
"Drug development is expensive"
"We need to recoup costs"
"We offer patient assistance programs"
Then AOC got her turn to question.
THE QUESTIONING: AOC VS. BIG PHARMA
AOC's Strategy:
She didn't ask vague questions. She came with receipts.
She had:
Financial documents
Ownership structures
Pricing data from multiple countries
Lobbying expenditure reports
Marketing budget breakdowns
And she systematically destroyed every excuse.
EXCHANGE 1: THE VERTICAL MONOPOLY
AOC: "Mr. [Executive], can you tell me—does your company own the pharmaceutical manufacturing plants where your drugs are made?"
Executive: "Yes, we own some of our manufacturing facilities."
AOC: "And do you own or have ownership stakes in pharmacy benefit managers (PBMs)—the middlemen who negotiate drug prices with insurers?"
Executive: "We have relationships with PBMs, yes."
AOC: "That's not what I asked. Do you OWN them? Do you have financial stakes in them?"
Executive: [Pause] "We have... partnerships and investments in some PBM entities."
AOC: "So to be clear: You manufacture the drug. You own part of the company that negotiates the price. You own the pharmacy that dispenses it. And you own the insurance company that decides whether to cover it. Is that correct?"
Executive: "It's more complicated than—"
AOC: "It's a yes or no question. Do you control multiple parts of the supply chain?"
Executive: "...Yes."
AOC then displayed a chart showing the ownership structure:
Pharmaceutical Company X owns:
Drug manufacturing (100%)
Pharmacy Benefit Manager (PBM) - 45% stake
Specialty pharmacy network - 60% ownership
Owns or partners with insurance providers who cover the drugs
The Translation:
The same company that:
Makes the drug (and sets the price)
Negotiates with insurers (through their PBM—and profits from both sides)
Dispenses the drug (through their pharmacies—and profits again)
Insures the patient (and decides whether to deny coverage)
They control EVERY step. And they profit from EVERY step.
EXCHANGE 2: THE PRICE GOUGING
AOC: "Your company sells [Drug X] in the United States for $1,500 per month. Is that correct?"
Executive: "That's the list price, yes, but—"
AOC: "And that same drug, made in the same factory, sold by your same company, costs $150 per month in Germany. Correct?"
Executive: "Different countries have different pricing structures—"
AOC: "It's the SAME DRUG. Same pill. Same factory. Same company. But Americans pay TEN TIMES MORE. Why?"
Executive: "The U.S. market allows for innovation and—"
AOC: "Let me stop you right there. Your company spent $2.1 billion on research and development last year. Do you know how much you spent on marketing and advertising?"
Executive: [Silence]
AOC: "I'll tell you. $4.8 billion. You spent MORE THAN TWICE AS MUCH on ads as you did on research. So let's stop pretending this is about innovation."
She then displayed a comparison chart:
CountryPrice for Drug X (per month)United States$1,500Germany$150France$160Canada$180UK$140Australia$170
Same drug. Same company. Americans pay 8-10x more.
EXCHANGE 3: THE INSURANCE SCAM
AOC: "Let's talk about insurance coverage. Your company denies coverage for [Drug Y] in approximately 40% of initial claims. Correct?"
Executive: "That's within industry standards for prior authorization—"
AOC: "So you make the drug. You set the price at $2,000 per month. Then YOUR insurance company—that you own a stake in—denies coverage 40% of the time. And then the patient either pays out of pocket—enriching you—or they appeal, and you delay treatment. Either way, you win. Correct?"
Executive: "We have patient assistance programs—"
AOC: "Your 'patient assistance programs' require patients to jump through hoops, provide extensive documentation, and wait months. And even then, they cover only a fraction of patients. Meanwhile, you made $8.2 billion in profit last year. Eight. Billion. Dollars. You're not running a charity. You're running a SCAM."
EXCHANGE 4: THE LOBBYING
AOC: "How much did your company spend on lobbying last year?"
Executive: "I don't have that figure in front of me—"
AOC: "I do. $36 million. You spent $36 million lobbying Congress to keep drug prices high, to prevent Medicare from negotiating prices, and to block imports of cheaper drugs from Canada. Is that correct?"
Executive: "We engage in advocacy to—"
AOC: "You BUY politicians. Let's call it what it is. You spend tens of millions of dollars to make sure laws protect YOUR profits, not patients' health."
She then showed lobbying expenditures for top pharmaceutical companies (2023 data):
Pharmaceutical Research and Manufacturers of America (PhRMA): $25.6 million
Pfizer: $14.2 million
Amgen: $13.8 million
Merck: $12.4 million
Johnson & Johnson: $11.9 million
Eli Lilly: $10.3 million
Total pharmaceutical industry lobbying (2023): Over $350 million.
That's more than the gun lobby. More than the oil lobby.
EXCHANGE 5: THE PATENT EVERGREENING
AOC: "Your company holds the patent for [Drug Z], which was approved in 2004. That patent should have expired in 2024, allowing generics to enter the market and reduce prices. But you still hold exclusive rights. How?"
Executive: "We made improvements to the formulation—"
AOC: "You changed the COLOR OF THE PILL. You didn't change the active ingredient. You didn't improve efficacy. You didn't improve safety. You changed it from blue to green and called it 'new and improved' to extend your patent by another 10 years. That's called 'evergreening,' and it's LEGAL FRAUD."
Patent Evergreening Explained:
When a drug patent is about to expire (allowing cheaper generics), pharmaceutical companies make tiny, medically insignificant changes:
Change the coating
Change the color
Combine two drugs into one pill
Change the delivery mechanism (e.g., extended-release)
Then they:
Apply for a new patent on the "improved" version
Stop making the old version
Force patients to switch to the new, expensive version
Block generics for another 10-20 years
Result: Patients pay high prices for decades longer than necessary.
EXCHANGE 6: THE FINAL BLOW
AOC: "Let me summarize what we've established today:
You manufacture the drug and set the price at whatever you want.
You own the middlemen who 'negotiate' prices—so you negotiate with yourself.
You own the pharmacies that dispense it—so you profit from dispensing.
You own stakes in insurance companies that decide coverage—so you profit whether they approve OR deny.
You spend more on marketing than research.
You charge Americans 10 times what you charge Europeans.
You lobby politicians to keep this system legal.
You manipulate patents to block cheaper generics.
And when patients can't afford their medication and die—you call it 'market forces.'
This isn't healthcare. This is a RACKET. And the American people are paying for it with their lives."
[Stunned silence in the hearing room]
THE AFTERMATH: WHAT HAPPENED NEXT
Immediate Response:
The clip went viral.
Millions of views across social media.
People were FURIOUS.
Comments flooded in:
"This is why my insulin costs $400/month"
"My mom died because she couldn't afford her cancer meds"
"I'm rationing my heart medication"
"This is why I'm moving to Canada"
Media Coverage:
Mainstream media barely covered it.
Why?
Because pharmaceutical companies are among the largest advertisers on TV news.
In 2023, the pharmaceutical industry spent $6.8 billion on direct-to-consumer advertising—mostly on TV.
Translation: News networks won't bite the hand that feeds them.
But independent media, TikTok, Twitter, YouTube—they exploded with coverage.
Congressional Action (Or Lack Thereof):
Did anything change after this hearing?
Sort of.
The Inflation Reduction Act (2022, implemented 2023-2024):
Allowed Medicare to negotiate prices on 10 drugs (a start, but only 10 out of thousands)
Capped insulin at $35/month for Medicare recipients (but not for people under 65 or without Medicare)
Capped out-of-pocket costs for Medicare Part D at $2,000/year (starting 2025)
But:
These reforms only apply to Medicare patients (not people with private insurance or no insurance)
Pharmaceutical companies are already finding loopholes
Drug prices for NON-Medicare patients continue to skyrocket
Why so little action?
Because pharmaceutical companies own Congress.
Between 2020-2024:
Pharmaceutical companies donated over $150 million to political campaigns
Both Democrats and Republicans receive money (though Republicans receive more)
Legislators who receive donations vote against drug pricing reform
It's legalized bribery.
THE BUSINESS MODEL EXPOSED: HOW BIG PHARMA PROFITS FROM EVERY ANGLE
Let me break down exactly how this scam works:
Step 1: Develop a Drug (Or Buy One)
Pharmaceutical companies often don't develop drugs from scratch.
They buy smaller biotech companies that did the hard work of research, then:
Rebrand the drug
Jack up the price
Claim they need high prices to "fund research" (even though they didn't do the research)
Example: AbbVie bought the rights to Humira (for autoimmune diseases) and turned it into the best-selling drug in history ($200+ billion in lifetime sales), despite not developing it.
Step 2: Set an Outrageous Price
Unlike every other developed country, the U.S. has NO PRICE CONTROLS on prescription drugs.
Pharmaceutical companies can charge whatever they want.
Example: Insulin costs $10 to manufacture. Companies charge $300-400 per vial in the U.S. (A 3,000-4,000% markup.)
Step 3: Own the Middlemen (PBMs)
Pharmacy Benefit Managers (PBMs) are supposed to negotiate lower prices on behalf of insurers and patients.
But guess what?
The three largest PBMs are owned by insurance companies and pharmaceutical companies:
CVS Caremark (owned by CVS Health, which also owns Aetna insurance)
Express Scripts (owned by Cigna insurance)
OptumRx (owned by UnitedHealth Group)
Translation: They're negotiating with themselves. And they profit from BOTH sides.
Step 4: Control the Pharmacies
Many pharmaceutical companies own pharmacies:
CVS Health owns CVS pharmacies AND Aetna insurance AND Caremark (PBM)
Cigna owns Express Scripts (PBM) AND partners with retail pharmacies
UnitedHealth Group owns OptumRx (PBM) AND mail-order pharmacies
So:
They make the drug
They "negotiate" the price
They dispense it
They profit at every step
Step 5: Deny Insurance Claims
Even though they OWN the insurance companies, they deny 30-40% of initial claims.
Why?
Because many patients give up after the first denial.
And even those who appeal:
Wait months
Jump through hoops
Many still get denied
Meanwhile:
Patients suffer without medication
Or pay out of pocket (enriching the company)
Or die
And the pharmaceutical company profits either way.
Step 6: Evergreen Patents to Block Generics
When patents are about to expire, companies make tiny, medically irrelevant changes to get new patents.
Example:
AstraZeneca's Prilosec (heartburn drug) patent was expiring
They created Nexium—literally the same drug, just the mirror-image molecule
Called it "new and improved"
Got a new patent
Charged $200/month instead of $20/month for generic Prilosec
This is LEGAL in the U.S.
Step 7: Lobby to Keep It All Legal
Pharmaceutical companies spend $350+ million per year lobbying to:
Prevent Medicare from negotiating prices
Block drug imports from Canada
Extend patent protections
Oppose price transparency laws
Kill "Medicare for All" proposals
They literally write the laws that govern them.
THE RESULT: AMERICANS DIE WHILE PHARMA PROFITS
The Human Cost:
According to research from Harvard Medical School and JAMA:
45,000 Americans die every year because they can't afford prescription medications
1 in 4 Americans report not taking medications as prescribed due to cost (skipping doses, cutting pills, rationing)
1.3 million Americans ration insulin (which can lead to diabetic ketoacidosis, coma, death)
Medical debt is the #1 cause of bankruptcy in the U.S. (62% of bankruptcies are medical-debt related)
People are dying.
Not because we lack medication.
Because they can't afford it.
THE RACIAL DISPARITY (BECAUSE OF COURSE THERE IS ONE)
According to the Commonwealth Fund and CDC:
Black and Hispanic Americans are:
Twice as likely to be uninsured or underinsured
More likely to ration medications due to cost
Less likely to afford copays for expensive medications
More likely to experience insurance claim denials
Result:
Higher rates of uncontrolled diabetes (can't afford insulin)
Higher rates of uncontrolled hypertension (can't afford blood pressure meds)
Higher rates of cardiovascular death
Pharmaceutical greed disproportionately kills Black and Brown people.
WHAT OTHER COUNTRIES DO (AND WHY IT WORKS)
Every other developed country has government price controls on prescription drugs.
How it works:
Canada:
Government negotiates prices with pharmaceutical companies
If companies refuse, government allows imports or generic production
Result: Drugs cost 50-80% less than in the U.S.
UK:
National Institute for Health and Care Excellence (NICE) evaluates cost-effectiveness
If a drug is too expensive relative to benefit, government won't cover it
Companies lower prices to get coverage
Result: Comprehensive coverage at fraction of U.S. prices
Germany:
Government sets maximum prices
Pharmaceutical companies must justify prices based on therapeutic value
Result: High-quality care, low costs
Why don't we do this in the U.S.?
Pharmaceutical lobbying.
They've convinced politicians (and some of the public) that:
"Price controls stifle innovation" (False—Europe produces plenty of new drugs)
"We need high prices to fund research" (False—they spend more on marketing than research)
"Socialism!" (False—it's capitalism WITH regulation, which every other industry has)
AOC'S PROPOSED SOLUTIONS
During and after the hearing, AOC has proposed:
1. Medicare for All
Single-payer system gives government negotiating power
Eliminates insurance middlemen
Covers everyone
2. Allow Medicare to Negotiate All Drug Prices
Not just 10 drugs—ALL drugs
Use purchasing power to lower costs
3. Ban Pharmaceutical Ownership of PBMs, Insurers, and Pharmacies
Break up vertical monopolies
Require independent middlemen
4. Cap Drug Prices Based on International Averages
If Germany pays $150, U.S. shouldn't pay $1,500
Tie U.S. prices to average of other developed countries
5. Allow Drug Imports from Canada and Europe
Safe, FDA-approved medications at lower prices
6. Reform Patent System
End evergreening
Require meaningful innovation for new patents
Shorten exclusivity periods
7. Ban Direct-to-Consumer Pharmaceutical Advertising
U.S. and New Zealand are the ONLY countries that allow it
Reduces marketing costs, reduces demand for unnecessary drugs
WHAT YOU CAN DO
1. Contact Your Representatives
Tell them:
Support Medicare price negotiation expansion
Support drug importation from Canada
Support patent reform
Oppose pharmaceutical lobbying influence
Find your representatives: house.gov, senate.gov
2. Support Candidates Who Refuse Pharma Money
Many candidates pledge not to take pharmaceutical donations.
Support them.
3. Share This Story
The more people understand how the system works, the more pressure on politicians to change it.
4. Use GoodRx, Cost Plus Drugs, and Other Discount Programs
Mark Cuban's Cost Plus Drug Company sells medications at cost + 15% markup (no insurance needed).
Example: 90-day supply of generic Lipitor (cholesterol med):
Retail price: $150
Cost Plus Drugs: $6.60
5. Advocate for Yourself
If your insurance denies coverage:
Appeal immediately (don't give up after first denial)
Ask your doctor to write a letter of medical necessity
Contact your state insurance commissioner
File complaints with your state attorney general
MB'S TAKE: AOC WAS RIGHT—AND WE NEED MORE LIKE HER
I don't agree with every policy AOC proposes.
But on this issue? She's 100% correct.
Pharmaceutical companies are running a legalized extortion racket.
They:
Control every step of the supply chain
Set outrageous prices
Deny coverage
Lobby to keep it legal
Profit while Americans die
This is not capitalism. This is corruption.
And it's killing us.
We need more elected officials willing to:
Ask hard questions
Bring receipts
Call out greed
Fight for patients over profits
We are not a brand, but a blueprint.
And the blueprint says: Healthcare is a human right. Medication should be affordable. And pharmaceutical greed should be illegal.
The system won't fix itself. We have to demand change.
SOURCES:
U.S. House Committee on Oversight and Accountability hearing transcripts (March 7, 2024)
C-SPAN video archives
OpenSecrets.org (pharmaceutical lobbying data)
Kaiser Family Foundation, drug pricing reports
JAMA, "Mortality Due to Medication Unaffordability" (2023)
Harvard Medical School, prescription drug affordability studies
Commonwealth Fund, health equity reports
Pharmaceutical company financial disclosures (2023-2024)
Medicare.gov, Inflation Reduction Act drug pricing provisions
Cost Plus Drugs (costplusdrugs.com)
Author's analysis and synthesis
WATCH THE FULL HEARING: C-SPAN archives: [Search "House Oversight pharmaceutical pricing 2024"]
FOLLOW AOC's WORK: Twitter/X: @AOC Instagram: @aoc House.gov: ocasio-cortez.house.gov
SHARE THIS ARTICLE.
Tag your representatives. Tag pharmaceutical companies. Tag news outlets that won't cover it.
Let them know we're watching. And we're not staying silent.
💛✊🏾 #BigPharmaGreed #HealthcareIsAHumanRight #MelaninBlissMedia
Next in the series: Coming soon.
We are not a brand, but a blueprint. And we're exposing the systems designed to profit from your pain.